clinical
-
Financial
Zimmer Biomet Adds 3D Range-of-Motion Simulation Capability with Strategic Acquisition of Clinical Graphics
WARSAW, Ind., Sept. 15, 2016 /PRNewswire/ — Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, recently…
Read More » -
Recon
Post-operative use of PICO™ Single use Negative Pressure Wound Therapy improves predictability in wound healing and reduces complications following orthopaedic surgery
Smith & Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces the publication of new clinical evidence highlighting improved…
Read More » -
Neuro
Asterias Biotherapeutics Receives Safety Clearance to Begin Administering the Highest Dose of AST-OPC1 in the SCiStar Phase 1/2a Clinical Trial in Cervical Spinal Cord Injury Patients
FREMONT, Calif., Aug. 31, 2016 /PRNewswire/ — Asterias Biotherapeutics, Inc. (NYSE MKT: AST), a biotechnology company focused on the emerging field of…
Read More » -
Hospitals
MiMedx Provides Update On Key Clinical Trials
MARIETTA, Ga., Aug. 30, 2016 /PRNewswire/ — MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes…
Read More » -
Spine
Intralink-Spine Continues To See Positive Clinical Results For The Treatment Of Low Back Pain
August 30, 2016 LEXINGTON, Ky.–(BUSINESS WIRE)–With the continuation of extremely positive clinical results at the 1-month juncture, Intralink-Spine, Inc. (ILS)…
Read More » -
Hospitals
CollPlant Reports Positive Final Extended Clinical Trial Results with Vergenix™STR for Treatment of Tendinopathy
Ness Ziona, Israel, August 17, 2016 – CollPlant Ltd. (TASE: CLPT), a regenerative medicine company utilizing its proprietary plant-based rhCollagen…
Read More » -
Recon
Clinical Studies Demonstrate ConforMIS iTotal CR Customized Knee Implants Provide Superior Outcomes and Potential for Economic Savings
BEDFORD, Mass., August 15, 2016 (GLOBE NEWSWIRE) — ConforMIS, Inc. (NASDAQ:CFMS), a medical technology company that develops, manufactures and sells…
Read More » -
Hospitals
BONESUPPORT™ Receives FDA Approval to Initiate IDE Clinical Study with CERAMENT™G
Lund, Sweden, 9 August – BONESUPPORT AB, an emerging leader in innovative injectable bioceramic bone substitute products to treat bone…
Read More » -
Biologics
Grafix® Manuscript Reporting Positive Outcomes of Multicenter Chronic Complex Wounds with Exposed Tendon and Bone Clinical Trial is Available Electronically in Peer-Reviewed Journal
COLUMBIA, Md., Aug. 04, 2016 (GLOBE NEWSWIRE) — Osiris Therapeutics, Inc. (NASDAQ:OSIR), a leading cellular regenerative medicine company focused on…
Read More » -
Hospitals
IlluminOss Medical Completes Enrollment for U.S. Clinical Trial Using Groundbreaking Photodynamic Bone Stabilization System
East Providence, RI (July 18, 2016) – IlluminOss Medical, a privately-held, commercial stage medical device company focused on minimally invasive…
Read More » -
Recon
First clinical use of intellijoint HIP’s® Direct Anterior Approach Application in Canada a success
July 8, 2016 (Waterloo, Ontario) – Intellijoint Surgical® – a privately held Canadian medical technology company committed to developing and commercializing…
Read More » -
Spine
SPINEART ANNOUNCES PUBLICATION OF CLINICAL DATA FOR ITS BAGUERA®C ARTIFICAL CERVICAL DISC PROSTHESIS
5 JULY 2016 Spineart announced today the results published in the Journal of Spine from a multicenter European prospective…
Read More » -
Spine
Dr. Marc A. Weinstein to Perform a Clinical Study With the FLXfit™ Lordotic Expandable Cage at Tampa General Hospital
OR AKIVA, Israel, July 5, 2016 /PRNewswire/ — Expanding Orthopedics Inc. (EOI), a privately held medical device company focused on…
Read More » -
Recon
Scientific abstract with the first 2 years’ clinical follow-up data on Episealer patients accepted for podium presentation at the Swedish Orthopedic’s week in Visby, 2016
This information was published, 2016-06-28 10:38 CEST (GLOBE NEWSWIRE) — The presentation “A personalised metal implant for resurfacing of local…
Read More » -
Extremities
Clinical Study in UK to Evaluate ReGenerCell for Diabetic Foot Ulcer Treatment
NORTHRIDGE, CA and PERTH, AUSTRALIA and CAMBRIDGE, UNITED KINGDOM — (Marketwired) — 05/30/16 — Avita Medical Ltd. (ASX: AVH) (OTCQX:…
Read More »